Description
Zoryve (roflumilast) is a prescription medication used to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is a type of drug called a phosphodiesterase-4 (PDE-4) inhibitor that works by reducing inflammation and swelling in the airways, as well as relaxing the smooth muscles in the lungs.
Uses:
Zoryve is used to treat adults with severe COPD, chronic bronchitis, and emphysema with a history of exacerbations. It is used to reduce inflammation and improve lung function, as well as prevent exacerbations.
Storage Conditions:
Zoryve should be stored at room temperature, between 68°F and 77°F (20°C and 25°C), in the original container, with the cap tightly closed. Do not freeze or expose to excessive heat or moisture.
Mechanism of Action:
Zoryve is a PDE-4 inhibitor that works by targeting the enzyme phosphodiesterase-4 (PDE-4), which is involved in the production of inflammatory mediators such as cytokines and chemokines that promote inflammation and swelling in the airways. By inhibiting PDE-4, Zoryve reduces the production of these inflammatory mediators, improving airway function and reducing exacerbations.
HOW TO USE:
Zoryve is taken orally once daily, with or without food, in the morning. The tablet should be swallowed whole, without crushing or chewing. Patients should follow the instructions provided by their healthcare provider.
Precautions:
Before taking Zoryve, inform your doctor if you have any allergies or have ever had an allergic reaction to this medication or any of its ingredients. Inform your doctor of any medical conditions, especially liver disease, that may prohibit the use of this medication. Zoryve may cause psychiatric symptoms such as depression, suicidal thoughts, or behavior. Seek medical attention if you experience any mood changes or abnormal thoughts.
Drug Interactions:
Zoryve may interact with certain medications, such as ketoconazole, rifampin, and erythromycin, which may increase the levels of Zoryve in the blood, leading to an increased risk of side effects. Inform your doctor if you are taking any medications, including prescription and over-the-counter drugs, vitamins, and supplements.
Contraindications:
Zoryve is contraindicated in patients with moderate or severe liver impairment or hypersensitivity to roflumilast or any of its ingredients.
Overdose:
In case of an overdose, seek emergency medical attention. Symptoms of an overdose with Zoryve may include nausea, vomiting, diarrhea, stomach pain, tremors, and insomnia.
Adverse Reactions:
The most common adverse reactions reported with Zoryve include diarrhea, weight loss, nausea, headache, and insomnia. Zoryve may also increase the risk of psychiatric symptoms, such as depression, suicidal thoughts, or behavior. If you experience any adverse reactions, inform your doctor or seek medical attention immediately.
In conclusion, Zoryve is a PDE-4 inhibitor medication used to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, in adults with severe COPD and a history of exacerbations. It works by reducing inflammation and swelling in the airways and relaxing the smooth muscles in the lungs. Before taking Zoryve, patients should inform their doctor of any allergies, medical conditions, or medication use. Zoryve is taken orally once daily, and common side effects include diarrhea, weight loss, nausea, headache, and insomnia. Zoryve may increase the risk of psychiatric symptoms, such as depression, suicidal thoughts, or behavior, and should not be used by individuals with liver impairment or hypersensitivity to the medication or any of its ingredients.
Reviews
There are no reviews yet.